A new medication for treatment-resistant depression may help a subset of people who carry a specific genetic marker.
The understanding of immune biology and the development of newer generations of immunotherapies have opened a new stage to ...
14h
Celltrion Signs Joint Research and Development Agreement with MustBio for Multi-Antibody New Drug
Celltrion announced on the 31st that it has signed a joint research and development agreement for a new immuno-oncology drug with MustBio, a domestic ...
Presentations to highlight ongoing clinical and translational research across PDS Biotechnology’s immunotherapy platforms ...
The presentation is available for download on the Anaptys website here.
Company aims to shorten time frame to make PDS0101 available to patients with HPV16-positive head and neck cancer, projected to be the most ...
The global cancer-therapy landscape is undergoing a rapid evolution toward precision drug-delivery systems designed to boost efficacy, ...
Innovative Achievements Continue to Come to Fruition, Revenue from Innovative Drugs Exceeding RMB6,700 Million in The First ...
Nanomedicine Innovations Transforming Oncology Drug Delivery And Bioavailability - Financial News Media. NetworkNewsWire Editorial Coverage New York, NY – October 29, 2025 – The global cancer-therapy ...
Merck Announces KEYTRUDA Plus WELIREG Met Primary Endpoint of DFS in Certain Patients With Clear Cell Renal Cell Carcinoma ...
Over the past decade, subcutaneous formulations of anticancer drugs—originally administered intravenously—have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback